Seeing tommorrow

Hope and Progress in Vision-Saving Research

As the medical destination for innovative research and treatment for retinal diseases, the Retina Foundation is leading the way to uncover impactful solutions for the 18 million people in the United States living with age-related macular degeneration (AMD), the leading cause of vision loss in people over the age of 50. Dr. Karl Csaky will present the latest breakthroughs in AMD therapies and innovations, offering a look at the future of sight-saving science. Dr. Srinivasa Sripathi will share exciting updates about the first-of-its-kind AMD sibling study, which has grown to 50 participants, including identical twins. The study has uncovered powerful insights into why two people with the same genes have different outcomes. AMD and other retinal degenerations impact entire families across generations, underscoring the importance and personal nature of this study. Laurie Litherland Dotter and her family will share their meaningful involvement in the Retina Foundation’s cutting-edge research and deep commitment in finding solutions.

Cocktails & Conversation
Wednesday, October 22, 2025
5:30 – 7 p.m.
Westwood Country Club
3808 West 35th Street | Austin, Texas 78703

Please RSVP by October 17 to Amy Johnson

ajohnson@retinafoundation.org | 214.543.6533

Presented By

DR. WILLIAM HUTTON

Retina Foundation Co-Founder
In Memory of his Friend and Co-Founder, Dr. Albert Vaiser
In Celebration of the Retina Foundation’s 50th Anniversary

Featuring

KARL CSAKY, MD, PhD

Chief Executive and Medical Officer
Director, Molecular Ophthalmology Laboratory
T. Boone Pickens Senior Scientist
Clinical Center of Innovation for AMD
Retina Foundation

SRINIVASA R. SRIPATHI, PhD

Director, Henderson Ocular Stem Cell Laboratory, Retina Foundation

LAURIE LITHERLAND DOTTER AND HER FAMILY

Chairman of the Board, Retina Foundation

Sponsors

The Retina Foundation is forever grateful that the Buena Vista Foundation and the Tapestry Foundation provided a $250,000 AMD Challenge Match in 2024, honoring their friend and the sibling study’s first participant, Jeanne Klein. Their generosity yielded a $500,000 total investment to help find a cure for AMD.

Get the Latest Updates

Sign up to receive the “Recently @Retina” newsletter to keep up-to-date.